Lin, Y. and Wang, Y. and Wang, W. and Deng, Z. and Zhang, Y. and Peng, Y. and Tang, J. and Li, J. and Huang, C. and Jian, D.
doi:10.1080/07853890.2026.2663263
Abstract
Tranexamic acid (TXA) is widely used for pigmentary disorders, but its anti-ageing potential remains unclear. This study aimed to evaluate whether topical 3% TXA improves early periorbital wrinkles in women with facial melasma and to investigate whether TXA protects human dermal fibroblasts from D-galactose-induced senescence